Iron treatment and inflammatory bowel disease: What happens in real practice?

Journal of Crohn's and Colitis

Volumn 8, Issue 8, 2014, Pages 876-880

  Lugg, Sebastian ^a   Beal, Felicity ^a   Nightingale, Peter ^a   Bhala, Neeraj ^a   Iqbal, Tariq ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anaemia; Inflammatory bowel disease; Iron

Indexed keywords

FERROUS FUMARATE; FERROUS GLUCONATE; FERROUS SULFATE; HEMOGLOBIN; IMMUNOMODULATING AGENT; IRON DEXTRAN; IRON DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ARTICLE; CONSTIPATION; CROHN DISEASE; DIARRHEA; DRUG EFFICACY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASE; IRON DEFICIENCY ANEMIA; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; NAUSEA; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; TABLET; TREATMENT DURATION; ULCERATIVE COLITIS; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG SAFETY; OUTCOME ASSESSMENT; QUESTIONNAIRE; RETROSPECTIVE STUDY; TREATMENT RESPONSE; ANEMIA, IRON-DEFICIENCY; COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; TREATMENT FAILURE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INFUSIONS, INTRAVENOUS; IRON COMPOUNDS; MALE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904499476     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.01.011     Document Type: Article

References (31)

1. Kulnigg S., Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006, 24(11-12):1507-1523.
2. Wilson A., Reyes E., Ofman J. Prevalence and outcomes of anaemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004, 116(Suppl. 7A):44S-49S.
3. Gasche C. Anaemia in IBD: the overlooked villain. Inflamm Bowel Dis 2000, 6(2):142-150.
4. De la Morena F., Gisbert J.P. Anaemia and inflammatory bowel disease. Rev Esp Enferm Dig 2008, 100(5):285-293.
5. Gasche C., Reinisch W., Lochs H., Parsaei B., Bakos S., Wyatt J., et al. Anaemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci 1994, 39:1930-1934.
6. Weis G., Goodnough L.T. Anaemia of chronic disease. N Eng J Med 2005, 352:1011-1023.
7. Yakut M., Ustun Y., Kabacam G., Soykan I. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med 2010, 21(4):320-323.
8. Pizzi L.T., Weston C.M., Goldfarb N.I., Goldfarb N.I., Cobb N., Cohen S., et al. Impact of chronic conditions with quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:47-52.
9. Wells C.W., Lewis S., Barton J.R., Corbett S. Effects of changes in haemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006, 12(2):123-130.
10. Verdon F., Burnand B., Fallab Stubi C.L., Bonard B., Graff M., Michaud A., et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ 2003, 326(7399):1124.
11. Gasche C., Berstad A., Befrits R., Beglinger C., Dignass A., Erichsen K., et al. Guidelines on the diagnosis and management of iron deficiency anaemia in inflammatory bowel disease. Inflamm Bowel Dis 2007, 13(2):1545-1553.
12. WHO, UNICEF, UNU Iron deficiency anaemia: assessment prevention and control. Report of a joint WHO/UNICEF/UNU consultation 1998, World Health Organization, Geneva.
13. Kerr D.N., Davidson S. Gastrointestinal intolerance to oral iron preparations. Lancet 1958, 2(7045):489-492.
14. Finch C. Regulators of iron balance in humans. Blood 1994, 84(6):1697-1702.
15. Erichsen K., Hausken T., Ulvik R.J., Svardal A., Berstad A., Berge R.K. Ferrous fumerate deteriorated plasma antioxidant status in patients with Crohn's disease. Scand J Gastroenterol 2003, 38:543-548.
16. Carrier J., Aghdassi E., Platt I., Cullen J., Allard J.P. Effect of iron supplementation on oxidative stress and intestinal inflammation in rat with induced colitis. Aliment Pharmacol Ther 2001, 15:1989-1999.
17. Lindgren S., Wikman O., Befrits R., Blom H., Eriksson A., Grännö C. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009, 44(7):838-845.
18. Vavricka S.R., Schoepfer A.M., Safroneeva E., Rogler G., Schwenkglenks M., Achermann R. A shift from oral to intravenous iron supplementation therapy is observed over time in a large swiss cohort of patients with inflammatory bowel disease. Inflamm Bowel Dis 2013, 19(4):840-846.
19. Hallberg L., Ryttinger L., Solvell L. Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form. Acta Med Scand Suppl 1966, 459:3-10.
20. Rocky D.C. Treatment of iron deficiency anaemia. Gastroenterology 2006, 130:1367-1368.
21. Zlotkin S., Arthur P., Antwi K.Y., Yeung G. Randomised, controlled trial of single versus 3-time-daily ferrous sulphate drop for treatment of anaemia. Pediatrics 2001, 108:613-616.
22. Makrides M., Crowther C.A., Gibson R.A., Gibson R.S., Skeaff C.M. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trail. Am J Clin Nutr 2003, 78(1):145-153.
23. Rimon E., Kaganksy N., Kagansky M., Mechnick L., Mashiah T., Namir M., et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 2005, 118(10):1142-1147.
24. de Silva A.D., Mylonaki M., Rampton D.S. Oral iron therapy in inflammatory bowel disease: usage, tolerance, and efficacy. Inflamm Bowel Dis 2003, 9:316-320.
25. de Silva A.D., Tsironi E., Feakins R.M., Rampton D.S. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective comparative trial. Aliment Pharmacol Ther 2005, 22(11-12):1097-1105.
26. Lee T.W., Kolber M.R., Fedorak R.N. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anaemia: a systematic review and meta-analysis. J Crohn's Colitis 2012, 6:267-275.
27. Schröder O., Mickisch O., Seidler U., de Weerth A., Dignass A.U., Herfarth H. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease - a randomized, controlled, open-label, multicenter study. Am J Gastronetrol 2005, 100:2503-2509.
28. Kulnigg S., Stoinov S., Simanenkov V., Dudar L.V., Karnafel W., Garcia L.C., et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008, 103(5):1182-1192.
29. Auerbach M., Ballard H., Glaspy J. Clinical update: intravenous iron for anaemia. Lancet 2007, 369:1502-1504.
30. Chertow G.M., Mason P.D., Vaage-Nilsen O., Ahlmén J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006, 21:378-382.
31. [accessed 25/09/2013]. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON300398.